Testing effectiveness (Phase 2)Active Not RecruitingNCT05053880
What this trial is testing
Evaluate Safety and Efficacy of ACT001 and Anti-PD-1 in Patients With Surgically Accessible Recurrent Glioblastoma Multiforme
Who this might be right for
Recurrent Glioblastoma Multiforme(GBM)
Accendatech USA Inc. 48